Related Experiment Videos
Elevated plasma glycoproteins in fetal sheep do not bind basic lipophilic drugs
Journal of Pharmaceutical Sciences
|September 1, 1986
Summary
N-acetylneuraminic acid (NANA)-containing glycoproteins in fetal sheep plasma do not accurately predict drug binding. Despite higher NANA levels, fetal drug binding was significantly lower than in adult sheep plasma.
Area of Science:
- Pharmacology
- Biochemistry
- Developmental Biology
Background:
- N-acetylneuraminic acid (NANA)-containing glycoproteins are key in adult plasma drug binding.
- Alpha 1-acid glycoprotein (AGP) is the primary binding protein for basic lipophilic drugs in adults.
Purpose of the Study:
- To evaluate the role of NANA-containing glycoproteins in fetal sheep plasma drug binding.
- To compare drug binding in fetal versus maternal sheep plasma.
Main Methods:
- Measurement of NANA concentrations in fetal and maternal sheep plasma.
- Assessment of propranolol, lidocaine, and methadone binding to plasma proteins.
- Calculation of bound-to-free drug concentration ratios.
Main Results:
- Fetal sheep plasma had significantly higher NANA concentrations than maternal plasma.
- Despite higher NANA, fetal drug binding was only 20-36% of maternal levels.
- NANA concentration did not correlate with drug binding in fetal plasma.
Conclusions:
- NANA-containing glycoproteins do not reliably predict basic lipophilic drug binding in fetal sheep plasma.
- AGP levels or function may differ significantly between fetal and adult sheep.
- Further research is needed to understand drug disposition in fetal mammals.